STIM Neuronetics, Inc. Stock Quote

STIM [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-1.68	Insider Own	5.60%	Shs Outstand	18.89M	Perf Week	-14.11%
Market Cap	372.59M	Forward P/E	-	EPS next Y	-0.78	Insider Trans	-6.20%	Shs Float	15.06M	Perf Month	-14.75%
Income	-31.40M	PEG	-	EPS next Q	-0.24	Inst Own	57.90%	Short Float	3.34%	Perf Quarter	77.87%
Sales	51.00M	P/S	7.31	EPS this Y	41.30%	Inst Trans	2.18%	Short Ratio	1.12	Perf Half Y	178.85%
Book/sh	1.45	P/B	10.37	EPS next Y	48.30%	ROA	-36.10%	Target Price	22.75	Perf Year	411.22%
Cash/sh	2.05	P/C	7.35	EPS next 5Y	-	ROE	-88.80%	52W Range	1.25 - 22.43	Perf YTD	35.28%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-34.00%	52W High	-32.99%	Beta	-
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	-	Gross Margin	76.50%	52W Low	1102.40%	ATR	2.06
Employees	122	Current Ratio	1.40	Sales Q/Q	-22.50%	Oper. Margin	-54.00%	RSI (14)	43.36	Volatility	12.56% 10.72%
Optionable	Yes	Debt/Eq	1.25	EPS Q/Q	51.20%	Profit Margin	-61.40%	Rel Volume	2.67	Prev Close	16.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Mar 02 BMO	Payout	-	Avg Volume	449.45K	Price	15.03
Recom	1.40	SMA20	-13.18%	SMA50	0.74%	SMA200	111.39%	Volume	1,200,864	Change	-9.13%

Jan-22-21

Upgrade

William Blair

Mkt Perform → Outperform

Feb-06-20

Initiated

BTIG Research

Buy

$11

Jul-24-18

Initiated

Canaccord Genuity

Buy

Mar-02-21 08:55AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates Zacks -9.13%
07:57AM	Neuronetics: Q4 Earnings Insights Benzinga
07:30AM	Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results GlobeNewswire
06:30AM	Neuronetics, Inc. to Host Earnings Call ACCESSWIRE
04:50AM	Neuronetics (STIM) Soars 6.5%: Is Further Upside Left in the Stock? Zacks
Mar-01-21 10:12AM	Earnings Outlook For Neuronetics Benzinga +6.50%
Feb-23-21 08:00AM	NeuroStar® Advanced Therapy Outcomes Registry Clinical Data Published in Brain Stimulation Validates Depression Treatment Protocols GlobeNewswire
Feb-16-21 07:00AM	Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call GlobeNewswire
Feb-11-21 08:00AM	Neuronetics Announces Strategic Leadership Promotions to Support Future Growth GlobeNewswire
Feb-10-21 07:00AM	Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference GlobeNewswire
Feb-02-21 04:05PM	Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares GlobeNewswire
Jan-28-21 10:30PM	Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock GlobeNewswire
04:01PM	Neuronetics Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-19-21 08:00AM	NeuroStar® Advanced Therapys Depression Outcomes Registry Hits 10,000 Patient Milestone GlobeNewswire +20.64%
Jan-14-21 05:06AM	What Type Of Shareholders Make Up Neuronetics, Inc.'s (NASDAQ:STIM) Share Registry? Simply Wall St.
Jan-12-21 04:05PM	Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial Results GlobeNewswire
Jan-11-21 12:29PM	Neuronetics (STIM) in Focus: Stock Moves 6.8% Higher Zacks -7.45%
Jan-07-21 04:30PM	Neuronetics to Participate at the 23rd Annual ICR Westwicke Conference GlobeNewswire +13.87%
08:00AM	Neuronetics Announces Expansion of Sales Organization GlobeNewswire
Dec-14-20 09:55PM	Is STIM A Good Stock To Buy Now? Insider Monkey
Dec-08-20 04:05PM	Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners GlobeNewswire
Nov-30-20 04:05PM	Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference GlobeNewswire
07:23AM	If You Had Bought Neuronetics (NASDAQ:STIM) Stock A Year Ago, You Could Pocket A 96% Gain Today Simply Wall St.
Nov-23-20 04:05PM	Neuronetics® Receives FDA Clearance for Three-Minute TouchStar Treatment Protocol GlobeNewswire
Nov-12-20 04:05PM	Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum GlobeNewswire
Nov-02-20 06:15PM	Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates Zacks +5.45%
04:05PM	Neuronetics Reports Third Quarter 2020 Financial and Operating Results GlobeNewswire
02:30PM	Neuronetics, Inc. to Host Earnings Call ACCESSWIRE
Oct-26-20 12:31PM	Neuronetics (STIM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-19-20 04:05PM	Neuronetics to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call GlobeNewswire
Oct-15-20 10:59AM	Is Neuronetics (NASDAQ:STIM) A Risky Investment? Simply Wall St.
Oct-13-20 08:00AM	Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder GlobeNewswire -5.35%
Oct-05-20 08:00AM	Neuronetics Appoints Sara Grubbs as Vice President, Sales GlobeNewswire
Oct-01-20 08:00AM	NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month GlobeNewswire
Sep-29-20 08:00AM	Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS GlobeNewswire +11.95%
Sep-22-20 08:00AM	Neuronetics Unveils New Depression Data at Clinical TMS Societys Virtual Events GlobeNewswire +9.79%
Aug-31-20 11:04AM	Have Insiders Been Buying Neuronetics, Inc. (NASDAQ:STIM) Shares This Year? Simply Wall St. +8.91%
Aug-04-20 08:45AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates Zacks +11.07%
07:30AM	Neuronetics Reports Second Quarter 2020 Financial and Operating Results GlobeNewswire
Jul-28-20 12:33PM	Analysts Estimate Neuronetics (STIM) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-21-20 08:00AM	Neuronetics to Report Second Quarter 2020 Financial and Operating Results and Host Conference Call GlobeNewswire
Jul-17-20 04:05PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +5.56%
08:57AM	Neuronetics (STIM) Looks Good: Stock Adds 11.3% in Session Zacks
Jul-14-20 04:15PM	Neuronetics Announces the Appointment of Keith J. Sullivan as President and Chief Executive Officer PR Newswire +5.88%
Jun-26-20 07:00AM	Neuronetics Announces Appointment of Bruce J. Shook to its Board of Directors GlobeNewswire
Jun-10-20 01:01PM	Hedge Funds Arent Crazy About Neuronetics, Inc. (STIM) Anymore Insider Monkey
Jun-04-20 04:30PM	Neuronetics to Present at the William Blair 40th Annual Growth Stock Conference GlobeNewswire
Jun-03-20 09:53AM	3 Strong Buy Healthcare Stocks Under $5 With Big Upside Potential TipRanks
May-12-20 05:21PM	Neuronetics, Inc. Announces Virtual 2020 Annual Meeting of Stockholders GlobeNewswire -8.26%
May-07-20 08:00AM	Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Month GlobeNewswire
May-05-20 07:30AM	Neuronetics (STIM) Reports Q1 Loss, Misses Revenue Estimates Zacks
06:00AM	Neuronetics Reports First Quarter 2020 Financial and Operating Results GlobeNewswire
Apr-21-20 08:00AM	Neuronetics to Report First Quarter 2020 Financial and Operating Results and Host Conference Call GlobeNewswire
Apr-09-20 02:35PM	Malvern medical device maker lays off, furloughs workers as it cuts expenses American City Business Journals +10.73%
07:52AM	The Daily Biotech Pulse: FDA Nod For Pfizer, Vanda Forges Partnership For COVID-19 Drug Research, Neuronetics Pre-Announces Revenue Shortfall Benzinga
Apr-08-20 04:11PM	Neuronetics, Inc. Adopts Limited Duration Shareholder Rights Plan GlobeNewswire +7.93%
04:10PM	Neuronetics, Inc. Announces Preliminary First Quarter 2020 Revenue, Corporate Restructuring, and Provides Business Update GlobeNewswire
09:44AM	Snap Up These 5 Stocks With Rising P/E Zacks
Mar-30-20 07:30AM	Neuronetics Recognized as 2020 Top Neurology Device Provider GlobeNewswire +28.30%
Mar-16-20 07:30AM	Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System GlobeNewswire -6.73%
Mar-13-20 01:18PM	Stephen Furlong Is The Chief Financial Officer of Neuronetics, Inc. (NASDAQ:STIM) And They Just Spent US$50k On Shares Simply Wall St. -5.02%
Mar-06-20 10:15AM	Malvern medical device company CEO departs; stock skyrockets American City Business Journals
08:49AM	The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study Benzinga
07:30AM	FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression GlobeNewswire
Mar-05-20 12:54PM	Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO GlobeNewswire
Mar-03-20 07:30AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates Zacks -15.65%
06:00AM	Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results GlobeNewswire
Feb-25-20 12:30PM	Earnings Preview: Neuronetics (STIM) Q4 Earnings Expected to Decline Zacks
Feb-18-20 08:00AM	Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Feb-13-20 07:00AM	GE Slashed Its Investment in This Slumping Medical-Tech Stock Barrons.com
Feb-12-20 04:05PM	Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO GlobeNewswire -5.56%
Jan-21-20 07:30AM	Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary GlobeNewswire
Jan-16-20 10:14AM	If You Had Bought Neuronetics (NASDAQ:STIM) Stock A Year Ago, You'd Be Sitting On A 72% Loss, Today Simply Wall St.
Dec-20-19 05:47PM	Neuronetics, Inc. (STIM) Is Burning These Hedge Funds Insider Monkey
Nov-25-19 07:30AM	Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-21-19 08:00AM	Daré Bioscience Closes Previously Announced Acquisition of Microchips Biotech with a First-in-Class Wireless, User-Controlled Drug Delivery Platform GlobeNewswire
Nov-07-19 07:30AM	Neuronetics® to Present New Depression Research at 15th Annual Neuroscience Education Institute Congress PR Newswire
Nov-05-19 08:45AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates Zacks -39.13%
07:30AM	Neuronetics Reports Third Quarter 2019 Financial and Operating Results GlobeNewswire
Nov-01-19 07:30AM	Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors GlobeNewswire
Oct-30-19 01:53PM	How Much Are Neuronetics, Inc. (NASDAQ:STIM) Insiders Taking Off The Table? Simply Wall St.
Oct-29-19 10:33AM	Analysts Estimate Neuronetics (STIM) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-28-19 07:30AM	Neuronetics® and Success TMS Partner to Increase Patient Access to Leading Depression Treatment, NeuroStar® Advanced Therapy PR Newswire
Oct-22-19 07:30AM	Neuronetics to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Oct-21-19 07:30AM	Neuronetics CEO Chris Thatcher to Ring Nasdaq Closing Bell on October 22 in Honor of National Depression Awareness Month PR Newswire
Oct-03-19 07:30AM	Neuronetics® Unveils Promising New Depression Research Data at Psych Congress PR Newswire
Oct-01-19 07:30AM	Neuronetics® Honors Depression Conquerors For National Depression Awareness Month PR Newswire
Sep-04-19 07:30AM	Neuronetics® Announces Greenbrook® TMS Installation Milestone for NeuroStar® Advanced Therapy System PR Newswire
Aug-27-19 01:15PM	Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way? Simply Wall St.
Aug-19-19 07:30AM	Researchers at USU Unveil Neuronetics®-supported Clinical Research for PTSD and Traumatic Brain Injury at the Military Health System Research Symposium PR Newswire
Aug-07-19 09:24PM	Neuronetics, Inc. (STIM) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 08:45AM	Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates Zacks
07:30AM	Neuronetics Reports Second Quarter 2019 Financial and Operating Results GlobeNewswire
Aug-01-19 07:30AM	Neuronetics® Announces First TMS Patient Treated Under New Japan Reimbursement Policy PR Newswire
Jul-29-19 07:30AM	Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients PR Newswire
Jul-25-19 04:30PM	Neuronetics to Present at the 39th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-23-19 08:00AM	Neuronetics to Report Second Quarter 2019 Financial and Operating Results and Host Conference Call GlobeNewswire
Jul-17-19 04:19PM	These 4 Medical Stocks Could Benefit From J&J Earnings Here's Why Investor's Business Daily
Jul-08-19 07:30AM	NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder PR Newswire
Jul-03-19 07:31AM	The Daily Biotech Pulse: Roche's Flu Drug Aces Late-Stage Trial, Acura Outlicenses Pain Medication, Neuronetics Gets New Finance Chief Benzinga

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sullivan Keith J	President and CEO	Feb 05	Sale	17.96	45,632	819,551	681,539	Feb 09 06:10 PM
Sullivan Keith J	President and CEO	Jan 26	Sale	18.83	22,829	429,870	602,171	Jan 28 09:42 PM
MACAN WILLIAM ANDREW	Sr. VP, GC, CCO and Secretary	Jan 22	Sale	21.28	12,696	270,171	188,453	Jan 25 09:26 PM
Harper Gregory	VP of Prod. Dev. & Operations	Jan 21	Sale	18.21	2,969	54,065	150,993	Jan 25 09:27 PM
Furlong Stephen	CFO	Jan 21	Sale	18.21	7,585	138,123	261,316	Jan 25 09:26 PM
Farley Brian E	Director	Mar 13	Buy	2.28	40,000	91,200	217,606	Mar 16 04:49 PM
Guthrie Daniel	Chief Commercial Officer	Mar 12	Buy	2.36	5,000	11,800	146,855	Mar 13 04:26 PM
Farley Brian E	Director	Mar 12	Buy	2.18	10,000	21,800	177,606	Mar 16 04:49 PM
Furlong Stephen	VP and CFO	Mar 10	Buy	2.00	25,000	50,000	274,184	Mar 11 05:31 PM
MACAN WILLIAM ANDREW	Sr. VP, GC, CCO and Secretary	Mar 10	Buy	2.00	5,000	10,000	182,399	Mar 11 05:28 PM
Thatcher Christopher	President and CEO	Mar 04	Option Exercise	0.87	20,000	17,400	249,811	Mar 04 08:16 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience